Dividend Assets Capital’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,175
| Closed | -$209K | – | 144 |
|
|
2025
Q4 | $209K | Sell |
2,175
-525
| -19% | -$51K | 0.04% | 133 |
|
|
2025
Q3 | $257K | Sell |
2,700
-2,512
| -48% | -$231K | 0.05% | 132 |
|
|
2025
Q2 | $454K | Sell |
5,212
-971
| -16% | -$82.3K | 0.08% | 113 |
|
|
2025
Q1 | $556K | Sell |
6,183
-2,441
| -28% | -$218K | 0.11% | 98 |
|
|
2024
Q4 | $689K | Sell |
8,624
-1,243
| -13% | -$108K | 0.13% | 88 |
|
|
2024
Q3 | $888K | Sell |
9,867
-159
| -2% | -$13.4K | 0.17% | 80 |
|
|
2024
Q2 | $789K | Sell |
10,026
-5,198
| -34% | -$426K | 0.16% | 81 |
|
|
2024
Q1 | $1.33M | Sell |
15,224
-37,851
| -71% | -$3.23M | 0.28% | 63 |
|
|
2023
Q4 | $4.37M | Sell |
53,075
-25,248
| -32% | -$1.92M | 0.86% | 37 |
|
|
2023
Q3 | $6.14M | Sell |
78,323
-1,550
| -2% | -$130K | 1.27% | 26 |
|
|
2023
Q2 | $7.04M | Buy |
79,873
+18,559
| +30% | +$1.6M | 1.45% | 16 |
|
|
2023
Q1 | $4.76M | Hold |
61,314
| – | – | 1.01% | 28 |
|
|
2022
Q4 | $4.76M | Sell |
61,314
-13,472
| -18% | -$1.09M | 1.01% | 28 |
|
|
2022
Q3 | $6.04M | Buy |
74,786
+2,911
| +4% | +$262K | 1.39% | 19 |
|
|
2022
Q2 | $6.45M | Sell |
71,875
-1,498
| -2% | -$152K | 1.39% | 19 |
|
|
2022
Q1 | $8.14M | Buy |
73,373
+1,993
| +3% | +$211K | 1.54% | 17 |
|
|
2021
Q4 | $7.38M | Buy |
71,380
+2,106
| +3% | +$244K | 1.37% | 20 |
|
|
2021
Q3 | $8.68M | Sell |
69,274
-667
| -1% | -$86.3K | 1.75% | 15 |
|
|
2021
Q2 | $8.68M | Sell |
69,941
-9,599
| -12% | -$1.21M | 1.7% | 15 |
|
|
2021
Q1 | $9.4M | Sell |
79,540
-1,464
| -2% | -$172K | 1.79% | 17 |
|
|
2020
Q4 | $9.49M | Sell |
81,004
-518
| -0.6% | -$57K | 1.84% | 15 |
|
|
2020
Q3 | $8.47M | Buy |
81,522
+2,589
| +3% | +$260K | 2.01% | 16 |
|
|
2020
Q2 | $7.24M | Buy |
78,933
+1,499
| +2% | +$144K | 1.52% | 18 |
|
|
2020
Q1 | $6.98M | Buy |
77,434
+4,990
| +7% | +$531K | 1.71% | 14 |
|
|
2019
Q4 | $8.22M | Buy |
72,444
+4,617
| +7% | +$507K | 1.33% | 20 |
|
|
2019
Q3 | $7.37M | Buy |
67,827
+1,945
| +3% | +$203K | 1.19% | 23 |
|
|
2019
Q2 | $6.42M | Buy |
65,882
+6,136
| +10% | +$560K | 1.02% | 27 |
|
|
2019
Q1 | $5.44M | Buy |
59,746
+3,200
| +6% | +$286K | 0.88% | 36 |
|
|
2018
Q4 | $5.14M | Buy |
56,546
+340
| +0.6% | +$31.8K | 0.9% | 36 |
|
|
2018
Q3 | $5.53M | Buy |
56,206
+2,734
| +5% | +$253K | 0.71% | 49 |
|
|
2018
Q2 | $4.58M | Sell |
53,472
-432,895
| -89% | -$36.2M | 0.6% | 52 |
|
|
2018
Q1 | $39M | Buy |
486,367
+322,720
| +197% | +$26.6M | 1.93% | 18 |
|
|
2017
Q4 | $13.2M | Buy |
+163,647
| New | +$13.1M | 0.59% | 55 |
|
|
2017
Q1 | – | Sell |
-3,202
| Closed | -$228K | – | 166 |
|
|
2016
Q4 | $228K | Sell |
3,202
-625
| -16% | -$49.1K | 0.01% | 139 |
|
|
2016
Q3 | $331K | Sell |
3,827
-1,142
| -23% | -$99.5K | 0.01% | 107 |
|
|
2016
Q2 | $431K | Sell |
4,969
-25
| -0.5% | -$2.02K | 0.01% | 95 |
|
|
2016
Q1 | $375K | Hold |
4,994
| – | – | 0.01% | 102 |
|
|
2015
Q4 | $384K | Buy |
4,994
+350
| +8% | +$26.3K | 0.01% | 101 |
|
|
2015
Q3 | $311K | Buy |
4,644
+127
| +3% | +$9.35K | 0.01% | 115 |
|
|
2015
Q2 | $335K | Sell |
4,517
-200
| -4% | -$15.3K | 0.01% | 116 |
|
|
2015
Q1 | $368K | Sell |
4,717
-1,182
| -20% | -$89.6K | 0.01% | 110 |
|
|
2014
Q4 | $426K | Buy |
5,899
+32
| +0.5% | +$2.22K | 0.01% | 106 |
|
|
2014
Q3 | $363K | Buy |
+5,867
| New | +$373K | 0.01% | 117 |
|
Other funds holding MDT
VCM
VPM
Dividend Assets Capital's MDT Position: Q1 2026 in Review
Dividend Assets Capital sold out of Medtronic (MDT) in Q1 2026, closing a stake of 2,175 shares — an estimated $209K sold.
Dividend Assets Capital first reported a position in MDT in Q3 2014 and held it in 43 quarters. The position peaked at $39M in Q1 2018. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Dividend Assets Capital reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
- Dividend Assets Capital sold 2,175 Medtronic shares in Q1 2026, an estimated $209K.
- Dividend Assets Capital first reported a position in Medtronic in Q3 2014 and held it in 43 quarters.
- Dividend Assets Capital's Medtronic position peaked at $39M in Q1 2018.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Dividend Assets Capital's 13F filing for Q1 2026, filed 28 Apr 2026.